Generic:
Moxaclav 625 is a combination drug containing Amoxicillin (500mg) and Clavulanic Acid (125mg), formulated to combat a wide range of bacterial infections.

Description:
Moxaclav 625 is a potent antibiotic medication used primarily for treating bacterial infections. Developed by Square Pharmaceuticals Ltd., this combination of Amoxicillin and Clavulanic Acid offers enhanced effectiveness by preventing the breakdown of Amoxicillin, thereby broadening its antibacterial scope.

Benefits:
Moxaclav 625 is highly effective for treating various infections, including those in the respiratory tract, genitourinary tract, skin, soft tissue, bones, and joints. Its composition addresses both Gram-positive and Gram-negative bacteria, ensuring comprehensive antibacterial action.

Ingredients:
Each Moxaclav 625 tablet contains Amoxicillin (500mg) and Clavulanic Acid (125mg), blended for optimal bacterial resistance and efficacy.

Uses and Doses:

• Adults and Children over 12 Years: One 625 mg tablet every 12 hours, or one 375 mg tablet every 8 hours. In severe cases, dosage can be increased.
• Children (6-12 years): 2 teaspoons every 8 hours; for 1-6 years, 1 teaspoon every 8 hours.
• Infants (below 1 year): 25 mg/kg daily in divided doses every 8 hours.

Side Effects:
Common side effects include mild gastrointestinal issues, such as diarrhea, nausea, and vomiting. Rarely, more serious side effects like skin rashes, hepatitis, and angioedema may occur. Most side effects subside after completing the treatment.

How to Use:
For maximum effectiveness, take Moxaclav 625 at the start of a meal to enhance absorption and minimize gastrointestinal discomfort. Intravenous forms should be administered slowly over 2 minutes or through a 30-minute infusion.

Pregnancy & Lactation:
Animal studies suggest no harmful effects on pregnancy, but its use is advised only if necessary. Amoxicillin traces may pass into breast milk during lactation.

Precautions and Warnings:
Moxaclav 625 should be used with caution in patients with liver or kidney issues, those on anticoagulation treatment, or with penicillin allergies. Adequate fluid intake is recommended to prevent crystalluria.

Safety Information:
Store below 25°C, away from light and moisture. Refrigerate reconstituted suspension, and do not freeze. Use within 7 days. Reconstituted vials must be used within 20 minutes.

Indications:
Moxaclav 625 is indicated for the short-term treatment of bacterial infections, including respiratory tract, genitourinary, skin, bone, and joint infections.

Pharmacology:
The pharmacology of Moxaclav 625 relies on its antibacterial properties. Amoxicillin inhibits bacterial cell wall synthesis, while Clavulanic Acid inactivates beta-lactamase enzymes, preventing antibiotic resistance.

Therapeutic Class:
Broad-spectrum penicillins.

Storage Conditions:
Keep Moxaclav 625 below 25°C, protected from light and moisture. Refrigerate suspension but avoid freezing.

FAQ

1. What infections can Moxaclav 625 treat?
   Moxaclav 625 is used to treat bacterial infections in the respiratory and urinary tracts, skin, bones, and soft tissues.
2. Can Moxaclav 625 be taken during pregnancy?
   It should only be taken if prescribed by a physician as necessary, with no known harm to the fetus in limited human cases.
3. How should Moxaclav 625 be stored?
   Store it below 25°C, and refrigerate reconstituted suspension, using it within 7 days.

Disclaimer:
The information provided here is for educational purposes and should not replace professional medical advice. Consult a healthcare provider before using Moxaclav 625 for proper dosage and possible interactions.

Keywords : Amoxicillin, Clavulanic Acid, Moxaclav 625, Square Pharmaceuticals, bacterial infection treatment, broad-spectrum antibiotic, respiratory infections, genitourinary infections, skin infections, bone infections, joint infections, antibiotic resistance, penicillin, beta-lactamase inhibitor, prescription medicine, antibiotic tablets, Bangladesh pharmaceuticals, ENT infections, sinusitis, bronchitis, osteomyelitis.